Abstract
4/2011
vol. 8
Stroke as a complication of acute coronary syndrome: questions to the neurologist
Kardiochirurgia i Torakochirurgia Polska 2011; 4: 534–538
Online publish date: 2011/12/28
Stroke is the most important cause of disability and one of the most important causes of death. About 1.40% of patients with acute coronary syndrome (ACS) suffer from stroke, of which about 2/3 are ischemic strokes. Intracranial hemorrhage is
a complication in about 1.43% of patients with myocardial infarction treated with thrombolysis. Dual antiplatelet therapy raises the risk of hemorrhagic complications, however it is not determined whether it raises the risk of intracranial hemorrhage. At present, there are no detailed guidelines for the management of patients with intracranial hemorrhage in the course of the dual antiplatelet therapy after ACS. Every patient with acute stroke should be treated in the stroke unit under supervision of the neurologist. At present, there are no recommendations for the routine use of any kind of neuroprotection in the stroke.
a complication in about 1.43% of patients with myocardial infarction treated with thrombolysis. Dual antiplatelet therapy raises the risk of hemorrhagic complications, however it is not determined whether it raises the risk of intracranial hemorrhage. At present, there are no detailed guidelines for the management of patients with intracranial hemorrhage in the course of the dual antiplatelet therapy after ACS. Every patient with acute stroke should be treated in the stroke unit under supervision of the neurologist. At present, there are no recommendations for the routine use of any kind of neuroprotection in the stroke.
Keywords
stroke, cerebral hemorrhage, acute coronary syndrome, complication, antiplatelet treatment, treatment, neuroprotection
Coverage in
Indexed in
Integrated with
Editorial Policies
